Seeing Is Believing
Currently out of the existing stock ratings of Leland Gershell, 132 are a BUY (94.96%), 2 are a SELL (1.44%), 5 are a HOLD (3.6%).
Analyst Leland Gershell works at OPPENHEIMER with a stock forecast success ratio of 30.71% fulfilled within 116.21 days on average.
Leland Gershell’s has documented 319 price targets and ratings displayed on 37 stocks. The coverage is on the Healthcare sector.
Most recent stock forecast was given on CPRX, Catalyst Pharmaceuticals at 27-Mar-2024.
Analyst best performing recommendations are on BXRX (BAUDAX BIO ).
The best stock recommendation documented was for SLNO (SOLENO THERAPEUTICS) at 9/15/2023. The price target of $14 was fulfilled within 11 days with a profit of $9.1 (185.71%) receiving and performance score of 168.83.
Average potential price target upside
Analyst name
Rating
Current price target
Potential distance
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Buy
2.5
$-0.28 (-10.07%)
1 years 1 months 13 days ago
1/1 (100%)
$1.86 (290.63%)
145
Buy
30
1 years 9 months 6 days ago
0/1 (0%)
$22.32 (290.63%)
Buy
3 years 6 months 26 days ago
0/1 (0%)
$59.52 (163.16%)
Which stock is Leland Gershell is most bullish on?
Which stock is Leland Gershell is most reserved on?
What Year was the first public recommendation made by Leland Gershell?